Click here to log in.
Guest Speakers: Professor Urlich Jager and Professor Dr. S. Eichinger
Subject: CLL and Lymphoma Treatments: New Standards and Practical Goals
Search for therapies, clinical trials and demographic information by country and subtype.
Article about the EMA orphan drug designation for PQR309 in DLBCL.
Article about the FDA granting Fast Track status to Epizyme‘s tazemetostat.
Article with details on approval of new Hodgkin Lymphoma drug.
The fourth annual Lymphoma Management course at Keble College Oxford, June 26th to 27th.
The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.
Copyright © 2017 Lymphoma Coalition. All rights reserved.